Loading...
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
BACKGROUND: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are treatment-resistant. The only evidence-based treatment for these patients is clozapine, an atypical antipsychotic with relatively weak dopamine antagonism. It is plausible that varying degrees of respons...
Na minha lista:
| Udgivet i: | BMC Psychiatry |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237235/ https://ncbi.nlm.nih.gov/pubmed/28086761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-016-1177-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|